postpartum pain. Maternal care for other conditions predominantly related to pregnancy
Conditions
Interventions
Intervention 1: Intervention group:Two hours after delivery, one 500 milligram curcumin capsule is given every 6 hours for 24 hours, and the severity of postpartum afterpains is assessed half an hour
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Be Iranian and speak Persian. Must be at least literate in reading and writing The mother's age should be between 18 and 35 years old. Delivery was performed vaginally. Singleton pregnancy with a gestational age of 37-42 weeks The outcome of the delivery was a live newborn without anomalies. So the pain is moderate to severe. The mother must be able to breastfeed and at least one breastfeeding session must have taken place within the first two hours after delivery. No pain medications or methods (epidural anesthesia, spinal anesthesia, Entonex, and pethidine) were used. The mother should not be addicted to drugs or alcohol. The baby's weight is between 4000-25000 grams. The mother does not have any chronic diseases (diabetes, high blood pressure, heart disease, and infectious diseases) based on the records and according to the mother's statement. The delivery was not performed with vacuum, forceps, or pressure on the uterine apex. The placenta and membranes should be expelled spontaneously. No history of allergy to herbal medicines Be able to take medication orally.
Exclusion criteria
Exclusion criteria: Unwillingness to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of pain. Timepoint: One and two hours after usage of drug. Method of measurement: visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of pain. Timepoint: one and two hour after usage of drug. Method of measurement: Pain checklist form.;Side effect. Timepoint: one and two hour after usage of drug. Method of measurement: Patient Drug Side Effects Assessment Form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Masoumeh Simbar
Shahid Beheshti University of Medical Sciences
Outcome results
None listed